Angiotensin II Type 1 Receptor Blockers: all 909 studies that test it
Page 6 of 10. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)CompletedNCT02186496Phase 1
- Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential HypertensionCompletedNCT02183701Phase 3
- Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan MonotherapyCompletedNCT02177500Phase 3
- Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate HypertensionCompletedNCT02177487Phase 3
- Telmisartan Compared With Enalapril in Elderly Patients With Blood HypertensionCompletedNCT02177461Phase 4
- BIBR 277 Capsule in Patients With Essential HypertensionCompletedNCT02177448Phase 3
- Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate HypertensionCompletedNCT02177435Phase 3
- Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate HypertensionCompletedNCT02177422Phase 3
- Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate HypertensionCompletedNCT02177409Phase 3
- MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure MonitoringCompletedNCT02177396Phase 3
- Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive PatientsCompletedNCT02172586Phase 4
- Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV InfectionCompletedNCT02170246Phase 1
- Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)CompletedNCT02152969Phase 1
- Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With HypertensionCompletedNCT02145104Phase 3
- Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With HyperlipidemiaStatus unknownNCT02087540Phase 3
- Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsTerminatedNCT02085265Phase 2
- Pharmacokinetic Drug Interaction Between Candesartan and RosuvastatinCompletedNCT02079506Phase 1
- CKD-330 Drug-Drug Interaction Study (Candesartan)CompletedNCT02064621Phase 1
- Efficacy and Safety of Shenyankangfu Tablets for Primary GlomerulonephritisStatus unknownNCT02063100Phase 4
- A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionStatus unknownNCT02059616Phase 2
- Intermittent Hypoxia 2: Cardiovascular and MetabolismTerminatedNCT02058823Phase 4
- PMS Study of Amlodipine/Valsartan for the Treatment of HypertensionCompletedNCT02058446Phase 4
- Comparative Study of the Effects of Telmisartan and NebivololStatus unknownNCT02057328Phase 4
- CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)CompletedNCT02047175Phase 1
- Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone SystemStatus unknownNCT02010905Phase 2
- Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting ConditionsCompletedNCT02006602Phase 1
- Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting ConditionsCompletedNCT02006589Phase 1
- Non-invasive Haemodynamic Assessment in HypertensionCompletedNCT01996085Not applicable
- Angiotensin II Antagonist in Severe SepsisStatus unknownNCT01992796Phase 3
- Losartan for Sickle Cell Kidney DiseaseCompletedNCT01989078Early Phase 1
- Comparision of Blood Pressure Variability Between Amlodipine and LosartanCompletedNCT01964079Phase 4
- Drug-Drug Interaction Study With PF-05089771CompletedNCT01934569Phase 1
- Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mgCompletedNCT01926652Phase 1
- Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mgCompletedNCT01918358Phase 1
- Supramaximal Titrated Inhibition of RAAS in Dilated CardiomyopathyCompletedNCT01917149Phase 4
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCMCompletedNCT01912534Phase 2
- Drug Interaction Study of Olmesartan in Healthy Chinese VolunteersCompletedNCT01907373Phase 4
- Pharmacokinetic Interactions of Losartan and HydrochlorothiazideCompletedNCT01858623Not applicable
- Drug Interaction Between Irbesartan and HydrochlorothiazideCompletedNCT01858610Not applicable
- Losartan in Decompensated Heart FailureCompletedNCT01857999Phase 4
- Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for HypertensionCompletedNCT01850160Phase 3
- Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine BesylateStatus unknownNCT01845272Phase 1
- Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipineCompletedNCT01842230Phase 1
- Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male VolunteersCompletedNCT01831479Phase 1
- HIGH Altitude CArdiovascular REsearch in the ANDESCompletedNCT01830530Phase 4
- RAS Quantification in Patients With Aliskiren or CandesartanCompletedNCT01827202Phase 4
- Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male SubjectsCompletedNCT01825850Phase 1
- Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic SyndromeCompletedNCT01819220Phase 4
- Pharmacokinetic Interactions and Safety Study of Telmisartan and ChlorthalidoneCompletedNCT01806363Phase 1
- Angiotensin II Receptor Blockers, Steroids and Radiotherapy in GlioblastomaCompletedNCT01805453Phase 3
- Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting ConditionsCompletedNCT01797926Phase 1
- Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)CompletedNCT01767298Not applicable
- Pharmacokinetic Interactions of Valsartan and HydrochlorothiazideCompletedNCT01767259Not applicable
- The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)TerminatedNCT01766505Phase 4
- Renal Response to Lower Body Negative Pressure in Pre-hypertensive StatesCompletedNCT01734096Phase 4
- Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted ConditionsCompletedNCT01712139Not applicable
- Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNCT01712126Not applicable
- Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted ConditionsCompletedNCT01712113Not applicable
- Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed ConditionsCompletedNCT01712100Not applicable
- Role of Inflammation Factors and Insulin Resistance in Major Depressive DisorderStatus unknownNCT01699490Phase 4
- Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + HydrochlorothiazideCompletedNCT01692717Phase 1
- Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic AneurysmsCompletedNCT01683084Phase 4
- To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureCompletedNCT01682564Phase 4
- Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine MonotherapyCompletedNCT01625494Phase 3
- Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension TreatmentSuspendedNCT01620788Phase 3
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedNCT01611077Phase 4
- New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure LoweringCompletedNCT01609959Phase 4
- Pharmacokinetic Drug Interaction Between Rosuvastatin and ValsartanCompletedNCT01609907Phase 1
- Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in HumanCompletedNCT01570569Phase 1
- The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on ProteinuriaCompletedNCT01541267Phase 4
- Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.CompletedNCT01541189Phase 4
- Preeclampsia: A Marker for Future Cardiovascular Risk in WomenSuspendedNCT01519297Not applicable
- Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic CardiomyopathyCompletedNCT01447654Phase 2
- Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric PatientsCompletedNCT01447485Phase 1
- Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) BlockerStatus unknownNCT01444833Not applicable
- Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AFCompletedNCT01435161Phase 4
- Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer TherapyCompletedNCT01434134Phase 2
- The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic SyndromeWithdrawnNCT01432106Phase 1
- Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular HypertrophyCompletedNCT01425411Phase 4
- Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 HypertensionCompletedNCT01415505Phase 3
- Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male VolunteersCompletedNCT01415466Phase 1
- Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy SubjectsCompletedNCT01406431Phase 1
- Blood Pressure Lowering in Acute Stroke TrialWithdrawnNCT01400256Phase 4
- CKD-828 Drug Interaction Study (Telmisartan)CompletedNCT01356017Phase 1
- Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, FedCompletedNCT01350609Phase 1
- Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene MutationsStatus unknownNCT01320397Phase 2
- The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis PatientsStatus unknownNCT01305850Phase 4
- Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionCompletedNCT01303783Phase 2
- Contribution of Angiotensin II to Supine Hypertension in Autonomic FailureTerminatedNCT01292694Phase 1
- PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung CancerCompletedNCT01281787Phase 3
- Use of Telmisartan and Captopril in Inflammation of Hemodialysis PatientsCompletedNCT01271478Phase 4
- Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic SyndromeStatus unknownNCT01271374Phase 4
- A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by MonotherapyCompletedNCT01241487Phase 4
- Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)CompletedNCT01232049Phase 1
- Telmisartan Versus Losartan in Kidney TransplantationCompletedNCT01224860Phase 2
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed ConditionsCompletedNCT01218724Phase 1
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.CompletedNCT01218711Phase 1
- Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed ConditionCompletedNCT01218698Phase 1
- Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting ConditionCompletedNCT01218022Phase 1
- Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed ConditionsCompletedNCT01216878Not applicable